Dorte Lisbet Nielsen

Dorte Lisbet Nielsen

Professor emeritus.

Member of:

  • Clinical Oncology


  1. Published

    A systematic review of bevacizumab efficacy in breast cancer

    Kümler, I., Christiansen, O. G. & Nielsen, Dorte Lisbet, Sep 2014, In: Cancer Treatment Reviews. 40, 8, p. 960-973 14 p.

    Research output: Contribution to journalReviewResearchpeer-review

  2. Published

    Clinical outcome of percutaneous RF-ablation of non-operable patients with liver metastasis from breast cancer

    Kümler, Iben, Parner, V. K., Tuxen, M. K., Skjoldbye, B., Bergenfeldt, M., Nelausen, K. M. & Nielsen, Dorte Lisbet, Jun 2015, In: La Radiologia Medica. 120, 6, p. 536-541 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    A systematic review of dual targeting in HER2-positive breast cancer

    Kümler, I., Tuxen, M. K. & Nielsen, Dorte Lisbet, Mar 2014, In: Cancer Treatment Reviews. 40, 2, p. 259-270 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Topoisomerase-1 gene copy aberrations are frequent in patients with breast cancer

    Kümler, I., Balslev, E., Poulsen, T. S., Nielsen, Signe Lykke, Nygård, S. B., Rømer, M. U., Christensen, I. J., Høgdall, E., Moreira, José, Nielsen, Dorte Lisbet, Brünner, N. & Stenvang, Jan, 8 Apr 2015, In: International Journal of Cancer. 137, 8, p. 2000-2006 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Dual Inhibition of EGFR and VEGF in Heavily Pretreated Patients with Metastatic Colorectal Cancer

    Larsen, F. O., Markussen, A., Nielsen, Dorte Lisbet, Colville-Ebeling, B., Riis, Lene Buhl & Jensen, B. V., Sep 2017, In: Oncology. 93, 3, p. 191-196 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Efficacy and Safety of Capecitabine, Irinotecan, Gemcitabine, and Bevacizumab as Second-Line Treatment in Advanced Biliary Tract Cancer: A Phase II Study

    Larsen, F. O., Markussen, A., Diness, L. V. & Nielsen, Dorte Lisbet, 2018, In: Oncology. 94, 1, p. 19-24

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Safety and feasibility of home-based chemotherapy

    Larsen, F. O., Christiansen, A. B., Rishøj, A., Nelausen, K. M. & Nielsen, Dorte Lisbet, 2018, In: Danish Medical Journal. 65, 5, 5 p., A5482.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    A systematic review of trastuzumab and lapatinib in the treatment of women with brain metastases from HER2-positive breast cancer

    Larsen, P. B., Kümler, Iben & Nielsen, Dorte Lisbet, 2013, In: Cancer Treatment Reviews. 39, 7, p. 720-727 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    A phase I, dose-escalation study of TB-403, a monoclonal antibody directed against PlGF, in patients with advanced solid tumours

    Lassen, Ulrik Niels, Nielsen, Dorte Lisbet, Sørensen, M., Winstedt, L., Niskanen, T., Stenberg, Y., Pakola, S., Stassen, J. & Glazer, S., 14 Feb 2012, In: B J C. 106, 4, p. 678-84 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Phase I evaluation of the effects of ketoconazole and rifampicin on cediranib pharmacokinetics in patients with solid tumours

    Lassen, Ulrik Niels, Miller, W. H., Hotte, S., Evans, T. R. J., Kollmansberger, C., Adamson, D., Nielsen, Dorte Lisbet, Spicer, J., Chen, E., Meyer, T., Brown, K., Rafi, R. & Sawyer, M. B., 2013, In: Cancer Chemotherapy and Pharmacology. 71, 2, p. 543-549 7 p.

    Research output: Contribution to journalLetterResearchpeer-review

ID: 10804194